The FDA suggests that prescribed users also reduce their calorie intake and increase their exercise The weight loss drug ...

The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...

called the FDA’s approval a "promising advancement for the millions of people who suffer from this condition." "Zepbound promotes weight loss and has been shown to reduce apnea events." ...

The FDA also recommends that ... Shelby Knowles/Bloomberg via Getty The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep ...

The AASM said patients on Zepbound should know that sustained weight loss is required for it to be effective against sleep apnea symptoms. The FDA approval comes amid growing discussion about the ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA). On Dec. 20 ... “Zepbound promotes weight loss and has been shown to reduce ...

21 (UPI) --Zepbound, the new GLP-1 weight-loss ... "Today's approval marks the first drug treatment option for certain patients with obstructive sleep apnea," said Dr. Sally Seymour of the FDA's ...

Never miss a story — sign up for PEOPLE's free daily newsletter to stay up-to-date on the best of what ... loss drugs approved to treat medical conditions other than obesity and diabetes. In March, ...

The Food and Drug Administration on Friday approved Eli Lilly’s ... the condition by reducing body weight, the FDA said. The move comes as weight-loss medications have garnered immense national ...